Form 4: Vireo Growth CEO Acquires 3.2 Million Shares in Stock Grant
SEC Form 4 Filing
Vireo Growth Inc.'s CEO, John Mazarakis, acquired 3.2 million subordinate voting shares through a stock grant.
Summary
- John Mazarakis, the CEO of Vireo Growth Inc., acquired 3,200,000 subordinate voting shares.
- The shares were granted under the company's 2019 Equity Incentive Plan, as amended.
- The shares vested immediately upon the grant date, which was December 17, 2024.
- The transaction was reported on a Form 4 filing with the SEC.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. The immediate vesting could be seen as a positive incentive.
Positives
- The grant of shares to the CEO aligns his interests with those of the shareholders.
- The immediate vesting of the shares could incentivize the CEO to focus on short-term performance.
Industry Context
Stock grants are a common form of executive compensation in publicly traded companies, particularly in growth-oriented sectors like the cannabis industry where Vireo Growth operates.
Comparison to Industry Standards
- Stock grants are a typical component of executive compensation packages across various industries, including the cannabis sector.
- Companies like Curaleaf, Trulieve, and Green Thumb Industries also utilize equity-based compensation to align management interests with shareholder value.
- The size of the grant is significant, but without further context on the company's overall compensation strategy, it's difficult to assess if it's above or below industry averages.
Stakeholder Impact
- The stock grant could be viewed positively by shareholders as it aligns the CEO's interests with the company's performance.
- The grant does not have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/17/2024 | Date of the stock grant to John Mazarakis. |
| 12/19/2024 | Date of the Form 4 filing. |
Keywords
Vireo Growth Inc., John Mazarakis, stock grant, subordinate voting shares, equity incentive plan, SEC Form 4, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.